The European Food Safety Authority (EFSA) has rejected probiotic dossiers from Canadian firm Lallemand Health Solutions (immunity) and Italian player Synbiotec (defecation) in a batch of opinions published today.
EFSA has issued a long-awaited immune and gut health claim guidance document it says draws on years of dossier assessment and includes biomarker updates, but a leading consultant was left unimpressed saying it “does not provide big news”.
Common gut bacteria from the class Clostridia could prevent sensitisation to allergens in food, according to new research that may pave the way for probiotic products aimed at battling food allergies and intolerances.
The probiotic strain Lactobacillus acidophilus decreases skin sensitivity in children that can reduce disorders like eczema, researchers have found after a scan of published studies – but other allergic ailments like asthma and wheezing were not affected.
Spanish supplier Biosearch Life is finding success with its patented, immune system-boosting and mastitis battling probiotic isolated from human breast milk in a world-first product launched in Australia this year.